Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity - Concepedia

Concepedia

Publication | Open Access

Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity

DOI Full Paper Access

327

Citations

58

References

2021

Year

Won Jin Ho, Qingfeng Zhu, Jennifer N. Durham, Aleksandra Popović, Stephanie Xavier, James M. Leatherman, Aditya Mohan, Guanglan Mo, Shu Zhang, Soren Charmsaz,

Nivolumab ConvertHepatologyMedicineImmunologyTumor ImmunityImmune Checkpoint InhibitorLiver CancerCancer TreatmentOncologyRadiation OncologyHepatocellular CarcinomaNeoadjuvant Cabozantinib

References

	Year	Citations

Page 1

Page 1